BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 28903345)

  • 61. Circulating miRNAs as Potential Biomarkers of Age-Related Macular Degeneration.
    Ren C; Liu Q; Wei Q; Cai W; He M; Du Y; Xu D; Wu Y; Yu J
    Cell Physiol Biochem; 2017; 41(4):1413-1423. PubMed ID: 28315863
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Circulating MiR-17-5p, MiR-126-5p and MiR-145-3p Are Novel Biomarkers for Diagnosis of Acute Myocardial Infarction.
    Xue S; Liu D; Zhu W; Su Z; Zhang L; Zhou C; Li P
    Front Physiol; 2019; 10():123. PubMed ID: 30833907
    [TBL] [Abstract][Full Text] [Related]  

  • 63. miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.
    Rinnerthaler G; Hackl H; Gampenrieder SP; Hamacher F; Hufnagl C; Hauser-Kronberger C; Zehentmayr F; Fastner G; Sedlmayer F; Mlineritsch B; Greil R
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26821018
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating microRNAs and sudden cardiac arrest outcomes.
    Wander PL; Enquobahrie DA; Pritchard CC; McKnight B; Rice K; Christiansen M; Lemaitre RN; Rea T; Siscovick D; Sotoodehnia N
    Resuscitation; 2016 Sep; 106():96-101. PubMed ID: 27423422
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum miR-338-3p and miR-199b-5p are associated with the absolute neutrophil count in patients with resectable pancreatic cancer.
    van der Sijde F; Vietsch EE; Mustafa DAM; Li Y; van Eijck CHJ
    Clin Chim Acta; 2020 Jun; 505():183-189. PubMed ID: 32145274
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction.
    Bidarra D; Constâncio V; Barros-Silva D; Ramalho-Carvalho J; Moreira-Barbosa C; Antunes L; Maurício J; Oliveira J; Henrique R; Jerónimo C
    Front Oncol; 2019; 9():900. PubMed ID: 31572685
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer.
    Ulivi P; Petracci E; Marisi G; Baglivo S; Chiari R; Billi M; Canale M; Pasini L; Racanicchi S; Vagheggini A; Delmonte A; Mariotti M; Ludovini V; Bonafè M; Crinò L; Grignani F
    J Clin Med; 2019 Jan; 8(2):. PubMed ID: 30678026
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Four plasma miRNAs act as biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Jiang HG; Dai CH; Xu YP; Jiang Q; Xia XB; Shu Y; Li J
    Oncol Lett; 2021 Nov; 22(5):792. PubMed ID: 34630703
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Microarray profiling defines circulating microRNAs associated with myelodysplastic syndromes.
    Dostalova Merkerova M; Hrustincova A; Krejcik Z; Votavova H; Ratajova E; Cermak J; Belickova M
    Neoplasma; 2017; 64(4):571-578. PubMed ID: 28485163
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer.
    Tao K; Yang J; Guo Z; Hu Y; Sheng H; Gao H; Yu H
    Am J Transl Res; 2014; 6(4):391-401. PubMed ID: 25075256
    [TBL] [Abstract][Full Text] [Related]  

  • 71. miRNAs in Sera of Tunisian patients discriminate between inflammatory breast cancer and non-inflammatory breast cancer.
    Hamdi K; Goerlitz D; Stambouli N; Islam M; Baroudi O; Neili B; Benayed F; Chivi S; Loffredo C; Jillson IA; Benammar Elgaaied A; Blancato JK; Marrakchi R
    Springerplus; 2014; 3():636. PubMed ID: 26034677
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Infrequently expressed miRNAs influence survival after diagnosis with colorectal cancer.
    Slattery ML; Pellatt AJ; Lee FY; Herrick JS; Samowitz WS; Stevens JR; Wolff RK; Mullany LE
    Oncotarget; 2017 Oct; 8(48):83845-83859. PubMed ID: 29137387
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of Circulating miR-22-3p and miR-93-5p as Stable Endogenous Control in Tuberculosis Study.
    Korma W; Mihret A; Tarekegn A; Chang Y; Hwang D; Tessema TS; Lee H
    Diagnostics (Basel); 2020 Oct; 10(11):. PubMed ID: 33114169
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Circulating miRNAs Associated With ER Stress and Organ Damage in a Preclinical Model of Trauma Hemorrhagic Shock.
    Luís A; Hackl M; Jafarmadar M; Keibl C; Jilge JM; Grillari J; Bahrami S; Kozlov AV
    Front Med (Lausanne); 2020; 7():568096. PubMed ID: 33072784
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diabetes Modulates MicroRNAs 29b-3p, 29c-3p, 199a-5p and 532-3p Expression in Muscle: Possible Role in GLUT4 and HK2 Repression.
    Esteves JV; Yonamine CY; Pinto-Junior DC; Gerlinger-Romero F; Enguita FJ; Machado UF
    Front Endocrinol (Lausanne); 2018; 9():536. PubMed ID: 30258406
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma.
    Zhou WD; Shao L; Dong L; Zhang RH; Li YF; Li HY; Wu HT; Shi XH; Wei WB
    Front Oncol; 2022; 12():854253. PubMed ID: 35433428
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.
    Díez-Planelles C; Sánchez-Lozano P; Crespo MC; Gil-Zamorano J; Ribacoba R; González N; Suárez E; Martínez-Descals A; Martínez-Camblor P; Álvarez V; Martín-Hernández R; Huerta-Ruíz I; González-García I; Cosgaya JM; Visioli F; Dávalos A; Iglesias-Gutiérrez E; Tomás-Zapico C
    Pharmacol Res; 2016 Jun; 108():102-110. PubMed ID: 27155059
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Postprandial Circulating miRNAs in Response to a Dietary Fat Challenge.
    Mantilla-Escalante DC; López de Las Hazas MC; Gil-Zamorano J; Del Pozo-Acebo L; Crespo MC; Martín-Hernández R; Del Saz A; Tomé-Carneiro J; Cardona F; Cornejo-Pareja I; García-Ruiz A; Briand O; Lasunción MA; Visioli F; Dávalos A
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31200481
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential MicroRNA Expression Levels in Cutaneous Acute Graft-Versus-Host Disease.
    Atarod S; Norden J; Bibby LA; Janin A; Ratajczak P; Lendrem C; Pearce KF; Wang XN; O'Reilly S; Van Laar JM; Collin M; Dickinson AM; Crossland RE
    Front Immunol; 2018; 9():1485. PubMed ID: 30042760
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tissue-specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non-small cell lung cancer.
    Pu Q; Huang Y; Lu Y; Peng Y; Zhang J; Feng G; Wang C; Liu L; Dai Y
    Thorac Cancer; 2016 Apr; 7(3):348-54. PubMed ID: 27148421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.